Research Output 1999 2017

2017

Bactericidal and sterilizing activity of a novel regimen with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

Li, S. Y., Tasneen, R., Tyagi, S., Soni, H., Converse, P. J., Mdluli, K. & Nuermberger, E. L. Sep 1 2017 In : Antimicrobial Agents and Chemotherapy. 61, 9, e00913-17

Research output: Contribution to journalArticle

Pyrazinamide
Tuberculosis
Drug Combinations
Recurrence
Multidrug-Resistant Tuberculosis

Drug resistance mechanisms and novel drug targets for tuberculosis therapy

Islam, M. M., Hameed, H. M. A., Mugweru, J., Chhotaray, C., Wang, C., Tan, Y., Liu, J., Li, X., Tan, S., Ojima, I., Yew, W. W., Nuermberger, E., Lamichhane, G. & Zhang, T. Jan 20 2017 In : Journal of Genetics and Genomics. 44, 1, p. 21-37 17 p.

Research output: Contribution to journalReview article

Drug Resistance
Tuberculosis
Multidrug-Resistant Tuberculosis
Mycobacterium tuberculosis
Genome

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

Kaushik, A., Ammerman, N. C., Tasneen, R., Story-Roller, E., Dooley, K. E., Dorman, S. E., Nuermberger, E. L. & Lamichhane, G. Aug 1 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2320-2325 6 p., dkx152

Research output: Contribution to journalArticle

Rifampin
Mycobacterium tuberculosis
In Vitro Techniques
Carbapenems
Drug Therapy

In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1

Gopal, P., Tasneen, R., Yee, M., Lanoix, J. P., Sarathy, J., Rasic, G., Li, L., Dartois, V., Nuermberger, E. & Dick, T. Jul 14 2017 In : ACS Infectious Diseases. 3, 7, p. 492-501 10 p.

Research output: Contribution to journalArticle

Carboxy-Lyases
Missense Mutation
Mycobacterium tuberculosis
Aspartic Acid
Acids

New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response

Bartelink, I. H., Zhang, N., Keizer, R. J., Strydom, N., Converse, P. J., Dooley, K. E., Nuermberger, E. L. & Savic, R. M. 2017 In : Clinical and Translational Science.

Research output: Contribution to journalArticle

Tuberculosis
Confidence Intervals
Anthralin
Rifampin
Pharmacokinetics

Primary clofazimine and bedaquiline resistance among isolates from patients with multidrug-resistant tuberculosis

Xu, J., Wang, B., Hu, M., Huo, F., Guo, S., Jing, W., Nuermberger, E. & Lu, Y. Jun 1 2017 In : Antimicrobial Agents and Chemotherapy. 61, 6, e00239-17

Research output: Contribution to journalArticle

Clofazimine
Multidrug-Resistant Tuberculosis
Mutation
Extensively Drug-Resistant Tuberculosis
Mycobacterium tuberculosis

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

Kendall, E. A., Shrestha, S., Cohen, T., Nuermberger, E., Dooley, K. E., Gonzalez-Angulo, L., Churchyard, G. J., Nahid, P., Rich, M. L., Bansbach, C., Forissier, T., Lienhardt, C. & Dowdy, D. W. Jan 1 2017 In : PLoS Medicine. 14, 1, e1002202

Research output: Contribution to journalArticle

Tuberculosis
Uncertainty
Rifampin
Mortality
Anthralin

Pyrazinoic acid inhibits a bifunctional enzyme in Mycobacterium tuberculosis

Njire, M., Wang, N., Wang, B., Tan, Y., Cai, X., Liu, Y., Mugweru, J., Guo, J., Hameed, H. M. A., Tan, S., Liu, J., Yew, W. W., Nuermberger, E., Lamichhane, G., Liu, J. & Zhang, T. Jul 1 2017 In : Antimicrobial Agents and Chemotherapy. 61, 7, e00070-17

Research output: Contribution to journalArticle

Pyrazinamide
Mycobacterium tuberculosis
Acids
Enzymes
Alleles

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Dheda, K. , Gumbo, T. , Maartens, G. , Dooley, K. E. , McNerney, R. , Murray, M. , Furin, J. , Nardell, E. A. , London, L. , Lessem, E. , Theron, G. , van Helden, P. , Niemann, S. , Merker, M. , Dowdy, D. , Van Rie, A. , Siu, G. K. H. , Pasipanodya, J. G. , Rodrigues, C. , Clark, T. G. & 22 others Sirgel, F. A., Esmail, A., Lin, H. H., Atre, S. R., Schaaf, H. S., Chang, K. C., Lange, C., Nahid, P., Udwadia, Z. F., Horsburgh, C. R., Churchyard, G. J., Menzies, D., Hesseling, A. C., Nuermberger, E., McIlleron, H., Fennelly, K. P., Goemaere, E., Jaramillo, E., Low, M., Jara, C. M., Padayatchi, N. & Warren, R. M. Apr 1 2017 In : The Lancet Respiratory Medicine. 5, 4, p. 291-360 70 p.

Research output: Contribution to journalReview article

Extensively Drug-Resistant Tuberculosis
Epidemiology
Tuberculosis
Multidrug-Resistant Tuberculosis
Pharmacokinetics
2016

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground

Srivastava, S., Deshpande, D., Pasipanodya, J. G., Thomas, T., Swaminathan, S., Nuermberger, E. & Gumbo, T. Nov 1 2016 In : Clinical Infectious Diseases. 63, p. S75-S79

Research output: Contribution to journalArticle

Tuberculosis
Drug Combinations
Pharmacokinetics
Clinical Trials
Age Groups

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way

Deshpande, D., Srivastava, S., Nuermberger, E., Pasipanodya, J. G., Swaminathan, S. & Gumbo, T. Nov 1 2016 In : Clinical Infectious Diseases. 63, p. S95-S101

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Stem Cells
Pediatrics
Pyrazinamide
Isoniazid

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo

Deshpande, D., Srivastava, S., Nuermberger, E., Pasipanodya, J. G., Swaminathan, S. & Gumbo, T. Nov 1 2016 In : Clinical Infectious Diseases. 63, p. S88-S94

Research output: Contribution to journalArticle

Tuberculosis
Mycobacterium tuberculosis
Appointments and Schedules
Pyrazinamide
Isoniazid

Contribution of oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in a mouse model of tuberculosis

Tasneen, R., Betoudji, F., Tyagi, S., Li, S. Y., Williams, K., Converse, P. J., Dartois, V., Yang, T., Mendel, C. M., Mdluli, K. E. & Nuermberger, E. L. Jan 1 2016 In : Antimicrobial Agents and Chemotherapy. 60, 1, p. 270-277 8 p.

Research output: Contribution to journalArticle

Oxazolidinones
Pyrazinamide
Tuberculosis
Nitroimidazoles
Multidrug-Resistant Tuberculosis

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children with Tuberculosis: Bread Crumb Trails in Random Forests

Swaminathan, S., Pasipanodya, J. G., Ramachandran, G., Kumar, A. K. H., Srivastava, S., Deshpande, D., Nuermberger, E. & Gumbo, T. Nov 1 2016 In : Clinical Infectious Diseases. 63, p. S63-S74

Research output: Contribution to journalArticle

Bread
Tuberculosis
Forests
Rifampin
Pyrazinamide

High systemic exposure of pyrazinoic acid has limited antituberculosis activity in murine and rabbit models of tuberculosis

Lanoix, J. P., Tasneen, R., O'Brien, P., Sarathy, J., Safi, H., Pinn, M., Alland, D., Dartois, V. & Nuermberger, E. Jul 1 2016 In : Antimicrobial Agents and Chemotherapy. 60, 7, p. 4197-4205 9 p.

Research output: Contribution to journalArticle

Tuberculosis
Rabbits
Acids
Pyrazinamide
Lung

Linezolid for Infants and Toddlers with Disseminated Tuberculosis: First Steps

Deshpande, D., Srivastava, S., Pasipanodya, J. G., Bush, S. J., Nuermberger, E., Swaminathan, S. & Gumbo, T. Nov 1 2016 In : Clinical Infectious Diseases. 63, p. S80-S87

Research output: Contribution to journalArticle

Area Under Curve
Tuberculosis
Mycobacterium tuberculosis
Microbial Sensitivity Tests
Half-Life

Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9

Ordonez, A. A., Tasneen, R., Pokkali, S., Xu, Z., Converse, P. J., Klunk, M. H., Mollura, D. J., Nuermberger, E. L. & Jain, S. K. Jul 1 2016 In : DMM Disease Models and Mechanisms. 9, 7, p. 779-788 10 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase 9
Pulmonary Tuberculoses
Tuberculosis
Cavitation
Anthralin

Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis

Almeida, D., Ioerger, T., Tyagi, S., Li, S. Y., Mdluli, K., Andries, K., Grosset, J., Sacchettini, J. & Nuermberger, E. Aug 1 2016 In : Antimicrobial Agents and Chemotherapy. 60, 8, p. 4590-4599 10 p.

Research output: Contribution to journalArticle

Clofazimine
Mycobacterium tuberculosis
Mutation
Multidrug-Resistant Tuberculosis
Genes

MYCOBACT-18 - Qualification des souris C3HeB/FeJ pour le traitement expérimental de la tuberculose

Lanoix, J. P., Schmit, J. L. & Nuermberger, E. Jun 1 2016 In : Medecine et Maladies Infectieuses. 46, 4, p. 84 1 p.

Research output: Contribution to journalArticle

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children with Disseminated Tuberculosis: Goldilocks

Srivastava, S., Deshpande, D., Pasipanodya, J., Nuermberger, E., Swaminathan, S. & Gumbo, T. Nov 1 2016 In : Clinical Infectious Diseases. 63, p. S102-S109

Research output: Contribution to journalArticle

Tuberculosis
Microbial Sensitivity Tests
Area Under Curve
Anti-Bacterial Agents
Meninges

Selective inactivity of pyrazinamide against tuberculosis in C3HeB/FeJ mice is best explained by neutral pH of caseum

Lanoix, J. P., Ioerger, T., Ormond, A., Kaya, F., Sacchettini, J., Dartois, V. & Nuermberger, E. Feb 1 2016 In : Antimicrobial Agents and Chemotherapy. 60, 2, p. 735-743 9 p.

Research output: Contribution to journalArticle

Pyrazinamide
Tuberculosis
Lung
Bacillus

Sterilizing activity of pyrazinamide in combination with first-line drugs in a C3HeB/FeJ mouse model of tuberculosis

Lanoix, J. P., Betoudji, F. & Nuermberger, E. Feb 1 2016 In : Antimicrobial Agents and Chemotherapy. 60, 2, p. 1091-1096 6 p.

Research output: Contribution to journalArticle

Pyrazinamide
Tuberculosis
Recurrence
Ethambutol
Isoniazid
National Institute of Allergy and Infectious Diseases (U.S.)
Critical Pathways
Tuberculosis
Pharmacology
Education
2015

A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections

Locher, C. P., Jones, S. M., Hanzelka, B. L., Perola, E., Shoen, C. M., Cynamon, M. H., Ngwane, A. H., Wiid, I. J., Van Helden, P. D., Betoudji, F., Nuermberger, E. L. & Thomson, J. A. Mar 1 2015 In : Antimicrobial Agents and Chemotherapy. 59, 3, p. 1455-1465 11 p.

Research output: Contribution to journalArticle

Tuberculosis
Infection
Prodrugs
Mycobacterium tuberculosis
Pyrazinamide

Assessing the Landscape of Tools and Approaches for Novel Tuberculosis Regimen Development

Nuermberger, E. & Hanna, D. Jun 15 2015 In : Journal of Infectious Diseases. 211, p. S81-S82

Research output: Contribution to journalArticle

Tuberculosis

Correlations between the hollow fiber model of tuberculosis and therapeutic events in tuberculosis patients: Learn and confirm

Gumbo, T., Pasipanodya, J. G., Nuermberger, E., Romero, K. & Hanna, D. 2015 In : Clinical Infectious Diseases. 61, p. S18-S24

Research output: Contribution to journalArticle

Tuberculosis
Pharmacokinetics
Meta-Analysis
Appointments and Schedules
Pyrazinamide

Daily rifapentine for treatment of pulmonary tuberculosis: A randomized, dose-ranging trial

Dorman, S. E., Savic, R. M., Goldberg, S., Stout, J. E., Schluger, N., Muzanyi, G., Johnson, J. L., Nahid, P., Hecker, E. J., Heilig, C. M., Bozeman, L., Feng, P. J. I., Moro, R. N., MacKenzie, W., Dooley, K. E., Nuermberger, E. L., Vernon, A. & Weiner, M. Feb 1 2015 In : American Journal of Respiratory and Critical Care Medicine. 191, 3, p. 333-343 11 p.

Research output: Contribution to journalArticle

Rifampin
Pulmonary Tuberculoses
Sputum
Pyrazinamide
Ethambutol

Efficacy of rifampin plus clofazimine in a murine model of Mycobacterium ulcerans disease

Converse, P. J., Tyagi, S., Xing, Y., Li, S. Y., Kishi, Y., Adamson, J., Nuermberger, E. L. & Grosset, J. H. Jun 4 2015 In : PLoS Neglected Tropical Diseases. 9, 6, e0003823

Research output: Contribution to journalArticle

Mycobacterium ulcerans
Clofazimine
Rifampin
Streptomycin
Clarithromycin

Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models

Li, S. Y., Irwin, S. M., Converse, P. J., Mdluli, K. E., Lenaerts, A. J. & Nuermberger, E. L. Jul 1 2015 In : Antimicrobial Agents and Chemotherapy. 59, 7, p. 4026-4030 5 p.

Research output: Contribution to journalArticle

Tuberculosis
Ethambutol
Isoniazid
Recurrence
Lung
Multidrug-Resistant Tuberculosis

Extensively drug-resistant tuberculosis in a young child after travel to India

Salazar-Austin, N., Ordonez, A. A., Hsu, A. J., Benson, J. E., Mahesh, M., Menachery, E., Razeq, J. H., Salfinger, M., Starke, J. R., Milstone, A. M., Parrish, N., Nuermberger, E. L. & Jain, S. K. Dec 1 2015 In : Lancet Infectious Diseases. 15, 12, p. 1485-1491 7 p.

Research output: Contribution to journalArticle

Extensively Drug-Resistant Tuberculosis
Tuberculosis
Teaching Rounds
Multidrug-Resistant Tuberculosis
Mycobacterium tuberculosis

Forecasting accuracy of the hollow fiber model of tuberculosis for clinical therapeutic outcomes

Gumbo, T., Pasipanodya, J. G., Romero, K., Hanna, D. & Nuermberger, E. 2015 In : Clinical Infectious Diseases. 61, p. S25-S31

Research output: Contribution to journalArticle

Tuberculosis
Confidence Intervals
Gold
Meta-Analysis
Appointments and Schedules

Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis

Lanoix, J. P., Lenaerts, A. J. & Nuermberger, E. L. Jun 1 2015 In : DMM Disease Models and Mechanisms. 8, 6, p. 603-610 8 p.

Research output: Contribution to journalArticle

Disease Progression
Tuberculosis
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide
Supravalvular Aortic Stenosis
Anthralin

Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives

Via, L. E. , Savic, R. , Weiner, D. M. , Zimmerman, M. D. , Prideaux, B. , Irwin, S. M. , Lyon, E. , O'Brien, P. , Gopal, P. , Eum, S. , Lee, M. , Lanoix, J. P. , Dutta, N. K. , Shim, T. S. , Cho, J. S. , Kim, W. , Karakousis, P. C. , Lenaerts, A. , Nuermberger, E. , Barry, C. E. & 1 others Dartois, V. May 8 2015 In : ACS Infectious Diseases. 1, 5, p. 203-214 12 p.

Research output: Contribution to journalArticle

Pyrazinamide
Acids
In Vitro Techniques
Tuberculosis
Pharmacokinetics

Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis

Gumbo, T., Lenaerts, A. J., Hanna, D., Romero, K. & Nuermberger, E. Jun 15 2015 In : Journal of Infectious Diseases. 211, p. S83-S95

Research output: Contribution to journalArticle

Drug Combinations
Tuberculosis
In Vitro Techniques
Forensic Anthropology
Appointments and Schedules

Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis

Irwin, S. M., Driver, E., Lyon, E., Schrupp, C., Ryan, G., Gonzalez-Juarrero, M., Basaraba, R. J., Nuermberger, E. L. & Lenaerts, A. J. Jun 1 2015 In : DMM Disease Models and Mechanisms. 8, 6, p. 591-602 12 p.

Research output: Contribution to journalArticle

Aerosols
Mycobacterium tuberculosis
Infection
Anthralin
Lung

Primary HIV infection presenting as limbic encephalitis and rhabdomyolysis

Ferrada, M. A., Xie, Y. & Nuermberger, E. Oct 24 2015 In : International Journal of STD and AIDS. 26, 11, p. 835-836 2 p.

Research output: Contribution to journalArticle

Limbic Encephalitis
Rhabdomyolysis
HIV Infections
Counseling

Shortening Tuberculosis Treatment with Fluoroquinolones: Lost in Translation?

Lanoix, J. P., Chaisson, R. E. & Nuermberger, E. L. Nov 4 2015 In : Clinical Infectious Diseases. 62, 4, p. 484-490 7 p.

Research output: Contribution to journalArticle

Fluoroquinolones
Tuberculosis
Pharmacokinetics
Clinical Trials

Systematic analysis of hollow fiber model of tuberculosis experiments

Pasipanodya, J. G., Nuermberger, E., Romero, K., Hanna, D. & Gumbo, T. 2015 In : Clinical Infectious Diseases. 61, p. S10-S17

Research output: Contribution to journalArticle

Tuberculosis
Drug Resistance
Pharmacokinetics
Mycobacterium tuberculosis
Meta-Analysis

Targeting DnaN for tuberculosis therapy using novel griselimycins

Kling, A. , Lukat, P. , Almeida, D. V. , Bauer, A. , Fontaine, E. , Sordello, S. , Zaburannyi, N. , Herrmann, J. , Wenzel, S. C. , König, C. , Ammerman, N. C. , Barrio, M. B. , Borchers, K. , Bordon-Pallier, F. , Brönstrup, M. , Courtemanche, G. , Gerlitz, M. , Geslin, M. , Hammann, P. , Heinz, D. W. & 12 others Hoffmann, H., Klieber, S., Kohlmann, M., Kurz, M., Lair, C., Matter, H., Nuermberger, E., Tyagi, S., Fraisse, L., Grosset, J. H., Lagrange, S. & Müller, R. Jun 5 2015 In : Science. 348, 6239, p. 1106-1112 7 p.

Research output: Contribution to journalArticle

Tuberculosis
Streptomyces
Mycobacterium tuberculosis
Multidrug-Resistant Tuberculosis
Gene Amplification
2014

Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.

Converse, P. J., Xing, Y., Kim, K. H., Tyagi, S., Li, S. Y., Almeida, D. V., Nuermberger, E. L., Grosset, J. H. & Kishi, Y. 2014 In : PLoS Neglected Tropical Diseases. 8, 1

Research output: Contribution to journalArticle

Mycobacterium ulcerans
Rifampin
Thin Layer Chromatography
Anti-Bacterial Agents
Clarithromycin

Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas

Irwin, S. M., Gruppo, V., Brooks, E., Gilliland, J., Scherman, M., Reichlen, M. J., Leistikow, R., Kramnik, I., Nuermberger, E. L., Voskuil, M. I. & Lenaerts, A. J. 2014 In : Antimicrobial Agents and Chemotherapy. 58, 7, p. 4026-4034 9 p.

Research output: Contribution to journalArticle

Clofazimine
Granuloma
Tuberculosis
Lung
Necrosis

Minding the gaps in tuberculosis research

Ekins, S., Nuermberger, E. L. & Freundlich, J. S. 2014 In : Drug Discovery Today. 19, 9, p. 1279-1282 4 p.

Research output: Contribution to journalArticle

Tuberculosis

Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: Nonlinearities in clearance and bioavailability

Savic, R. M., Lu, Y., Bliven-Sizemore, E., Weiner, M., Nuermberger, E., Burman, W., Dorman, S. E. & Dooley, K. E. 2014 In : Antimicrobial Agents and Chemotherapy. 58, 6, p. 3035-3042 8 p.

Research output: Contribution to journalArticle

Biological Availability
Healthy Volunteers
Pharmacokinetics
Tuberculosis
Clinical Trials

Principes de conception de futurs schémas thérapeutiques pour traiter la tuberculose multirésistante

Brigden, G., Nyang'wa, B. T., du Cros, P., Varaine, F., Hughes, J., Rich, M., Horsburgh, C. R., Mitnick, C. D., Nuermberger, E., McIlleron, H., Phillips, P. P. J. & Balasegaram, M. 2014 In : Bulletin of the World Health Organization. 92, 1, p. 68-74 7 p.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Extensively Drug-Resistant Tuberculosis
Plague
Poisons
Mycobacterium tuberculosis
2013

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease

Almeida, D. V., Converse, P. J., Li, S. Y., Tyagi, S., Nuermberger, E. L. & Grosset, J. H. Feb 2013 In : PLoS Neglected Tropical Diseases. 7, 2, e2085

Research output: Contribution to journalArticle

Mycobacterium ulcerans
Streptomycin
Rifampin
Buruli Ulcer
Withholding Treatment

Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis

Ahmad, Z., Tyagi, S., Minkowski, A., Peloquin, C. A., Grosset, J. H. & Nuermberger, E. L. Jul 1 2013 In : American Journal of Respiratory and Critical Care Medicine. 188, 1, p. 97-102 6 p.

Research output: Contribution to journalArticle

Pyrazinamide
Levofloxacin
Tuberculosis
Fluoroquinolones
Ethionamide
Fluoroquinolones

Pipeline of drugs for related diseases: Tuberculosis

Dooley, K. E., Nuermberger, E. L. & Diacon, A. H. Nov 2013 In : Current Opinion in HIV and AIDS. 8, 6, p. 579-585 7 p.

Research output: Contribution to journalArticle

Tuberculosis
Multidrug-Resistant Tuberculosis
Nitroimidazoles
Latent Tuberculosis
Rifamycins